RT Journal Article
T1 Impacto de la COVID-19 en el tratamiento del infarto agudo de miocardio con elevación del segmento ST. La experiencia española.
T2 [Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience].
A1 Rodriguez-Leor, Oriol
A1 Cid-Alvarez, Belen
A1 Perez de Prado, Armando
A1 Rossello, Xavier
A1 Ojeda, Soledad
A1 Serrador, Ana
A1 Lopez-Palop, Ramon
A1 Martin-Moreiras, Javier
A1 Rumoroso, Jose Ramon
A1 Cequier, Angel
A1 Ibañez, Borja
A1 Cruz-Gonzalez, Ignacio
A1 Romaguera, Rafael
A1 Moreno, Raul
A1 Villa, Manuel
A1 Ruiz-Salmeron, Rafael
A1 Molano, Francisco
A1 Sanchez, Carlos
A1 Muñoz-García, Erika
A1 Iñigo, Luis
A1 Herrador, Juan
A1 Gomez-Menchero, Antonio
A1 Gomez-Menchero, Antonio
A1 Caballero, Juan
A1 Ojeda, Soledad
A1 Cardenas, Mérida
A1 Gheorghe, Livia
A1 Oneto, Jesus
A1 Morales, Francisco
A1 Valencia, Felix
A1 Ruiz, Jose Ramon
A1 Diarte, Jose Antonio
A1 Avanzas, Pablo
A1 Rondan, Juan
A1 Peral, Vicente
A1 Pernasetti, Lucia Vera
A1 Hernandez, Julio
A1 Bosa, Francisco
A1 Lorenzo, Pedro Luis Martin
A1 Jimenez, Francisco
A1 Hernandez, Jose M de la Torre
A1 Jimenez-Mazuecos, Jesus
A1 Lozano, Fernando
A1 Moreu, Jose
A1 Novo, Enrique
A1 Robles, Javier
A1 Moreiras, Javier Martin
A1 Fernandez-Vazquez, Felipe
A1 Amat-Santos, Ignacio J
A1 Gomez-Hospital, Joan Antoni
A1 Garcia-Picart, Joan
A1 Blanco, Bruno Garcia Del
A1 Regueiro, Ander
A1 Carrillo-Suarez, Xavier
A1 Tizon, Helena
A1 Mohandes, Mohsen
A1 Casanova, Juan
A1 Agudelo-Montañez, Víctor
A1 Muñoz, Juan Francisco
A1 Franco, Juan
A1 Del Castillo, Roberto
A1 Salinas, Pablo
A1 Elizaga, Jaime
A1 Sarnago, Fernando
A1 Jimenez-Valero, Santiago
A1 Rivero, Fernando
A1 Oteo, Juan Francisco
A1 Alegria-Barrero, Eduardo
A1 Sanchez-Recalde, Angel
A1 Ruiz, Valeriano
A1 Pinar, Eduardo
A1 Pinar, Eduardo
A1 Planas, Ana
A1 Ledesma, Bernabe Lopez
A1 Berenguer, Alberto
A1 Fernandez-Cisnal, Agustin
A1 Aguar, Pablo
A1 Pomar, Francisco
A1 Jerez, Miguel
A1 Torres, Francisco
A1 Garcia, Ricardo
A1 Frutos, Araceli
A1 Nodar, Juan Miguel Ruiz
A1 Garcia, Koldobika
A1 Saez, Roberto
A1 Torres, Alfonso
A1 Telleria, Miren
A1 Sadaba, Mario
A1 Minguez, Jose Ramon Lopez
A1 Merchan, Juan Carlos Rama
A1 Portales, Javier
A1 Trillo, Ramiro
A1 Aldama, Guillermo
A1 Fernandez, Saleta
A1 Santas, Melisa
A1 Perez, Maria Pilar Portero
K1 COVID-19
K1 Primary angioplasty
K1 STEMI
K1 STEMI network
K1 Angioplastia primaria
K1 Red de atención al infarto
AB The COVID-19 outbreak has had an unclear impact on the treatment and outcomes of patients with ST-segment elevation myocardial infarction (STEMI). The aim of this study was to assess changes in STEMI management during the COVID-19 outbreak. Using a multicenter, nationwide, retrospective, observational registry of consecutive patients who were managed in 75 specific STEMI care centers in Spain, we compared patient and procedural characteristics and in-hospital outcomes in 2 different cohorts with 30-day follow-up according to whether the patients had been treated before or after COVID-19. Suspected STEMI patients treated in STEMI networks decreased by 27.6% and patients with confirmed STEMI fell from 1305 to 1009 (22.7%). There were no differences in reperfusion strategy (> 94% treated with primary percutaneous coronary intervention in both cohorts). Patients treated with primary percutaneous coronary intervention during the COVID-19 outbreak had a longer ischemic time (233 [150-375] vs 200 [140-332] minutes, P  94% treated with primary percutaneous coronary intervention in both cohorts). Patients treated with primary percutaneous coronary intervention during the COVID-19 outbreak had a longer ischemic time (233 [150-375] vs 200 [140-332] minutes, P  The number of STEMI patients treated during the current COVID-19 outbreak fell vs the previous year and there was an increase in the median time from symptom onset to reperfusion and a significant 2-fold increase in the rate of in-hospital mortality. No changes in reperfusion strategy were detected, with primary percutaneous coronary intervention performed for the vast majority of patients. The co-existence of STEMI and SARS-CoV-2 infection was relatively infrequent.
AB Introducción y objetivos: El impacto del brote de COVID-19 en el tratamiento del infarto agudo de miocardio con elevación del segmento ST (IAMCEST) no esta´ claro. El objetivo de este estudio es evaluar los cambios en el tratamiento del IAMCEST durante el brote de COVID-19. Métodos: Se utilizo´ un registro multice´ntrico, nacional, retrospectivo y observacional de pacientes consecutivos atendidos en 75 centros, se compararon las caracterı´sticas de los pacientes y de los procedimientos y los resultados hospitalarios en 2 cohortes segu´ n se los hubiera tratado antes o durantela COVID-19. Resultados: Los casos con sospecha de IAMCEST disminuyeron el 27,6% y los pacientes con IAMCEST confirmado se redujeron de 1.305 a 1.009 (22,7%). No hubo diferencias en la estrategia de reperfusio´n(ma´ s del 94% tratados con angioplastia primaria). El tiempo de isquemia fue ma´ s largo durante la COVID-19 (233 [150-375] frente a 200 [140-332] min; p < 0,001), sin diferencias en el tiempo primer contacto me´dico-reperfusio´n. La mortalidad hospitalaria fue mayor durante la COVID-19 (el 7,5 frente al 5,1%; OR bruta = 1,50; IC95%, 1,07-2,11; p < 0,001); esta asociacio´n se mantuvo tras ajustar por factores de confusio´n (OR ajustada = 1,88; IC95%, 1,12-3,14; p = 0,017). La incidencia de infeccio´n confirmada por SARS-CoV-2 fue del 6,3%. Conclusiones: El brote de COVID-19 ha implicado una disminucio´n en el nu´ mero de pacientes conIAMCEST, un aumento del tiempo entre el inicio de los sı´ntomas y la reperfusio´n y un aumento en la mortalidad hospitalaria. No se han detectado cambios en la estrategia de reperfusio´n. La combinacio´n de infeccio´n por SARS-CoV-2 e IAMCEST fue relativamente infrecuente.
PB Elsevier
YR 2020
FD 2020-10-09
LK http://hdl.handle.net/10668/16442
UL http://hdl.handle.net/10668/16442
LA es
NO Rodríguez-Leor O, Cid-Álvarez B, Pérez de Prado A, Rossello X, Ojeda S, Serrador A, et al. [Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience]. Rev Esp Cardiol. 2020 Dec;73(12):994-1002. Spanish
DS RISalud
RD Apr 7, 2025